Skip to main content
ANSTO's nuclear medicine manufacturing
Health

Facilities

ANSTO supplies a wide range of nuclear medicines via our licensed facilities. 

All our nuclear medicine products are manufactured at ANSTO in Good Manufacturing Practice (GMP) licensed clean rooms. Our facilities are licensed by the Therapeutic Goods Administration. Our adherence to strict quality assurance and control ensures the safety and efficacy of the products.

Mid way through 2019, ANSTO began the manufacture of molybdenum-99 (Mo-99) through a new state-of-the-art nuclear medicine manufacturing facility. 

Australia is one of only two countries in the world that has the facilities to complete all the steps required to produce and deliver Mo-99, which then decays to form Tc-99m, to medical practices

  • OPAL

    Step 1

    OPAL reactor

    Production of molybdenum-99 (Mo-99), the precursor to technetium-99m (Tc-99m), begins in ANSTO's OPAL reactor.

    Learn more
  • M-99 Manufacturing

    Step 2

    Mo-99 Manufacturing Facility

    Following irridation low-enriched uranium target plates are transported to ANSTO’s Mo-99 Manufacturing Facility to separate, purify and extract the Mo-99.

    Learn more
  • Processing and distribution facility

    Step 3

    Processing and distribution facility

    The final steps to prepare Mo-99 ftake place in our Nuclear medicine processing and distribution facility, also known as Building 23. This facility also assembles, loads, tests and distributes a range of other nuclear medicine products.

    View our full list of products
  • Gentech Tc-99 Generators

    Step 4

    ANSTO's Gentech Generators

    The most widely used radioisotope in nuclear medicine, technetium-99 (Tc-99m), decays from it's parent radioisotope molybdenum-99 within these shielded Gentech® Generators which are manufactured by ANSTO. 

    Find out more about Tc-99m
  • Delivery to medical practices

    Step 5

    Delivering nuclear medicine across Australia

    ANSTO delivers thousands of patient doses of Tc-99m to hospitals and nuclear medicine centres in Australian and the region every week. 

OPAL multi-purpose reactor

Mo-99 Manufacturing Facility

Processing and distribution

Ask us a question

If you would like to place a product order or have any further questions please contact the Health team.